☆ 4.5 Review

Animal models of acute exacerbation of pulmonary fibrosis

RESPIRATORY RESEARCH (2023)

Related references

Note: Only part of the references are listed.
Article Respiratory System

Idiopathic pulmonary fibrosis: state of the art for 2023

Anna J. Podolanczuk et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with worsening respiratory symptoms and physiological impairment. The prevalence of IPF has been increasing due to improved awareness, increased use of computed tomography scans, and other factors. There have been significant advances in understanding the pathobiology of IPF and identifying genetic and nongenetic contributors. The disease course and progression of IPF are unpredictable, and treatment with antifibrotic therapies can slow down decline of lung function.

EUROPEAN RESPIRATORY JOURNAL (2023)

Add to Collection
Article Integrative & Complementary Medicine

Aqueous extract of Platycodon grandiflorus attenuates lipopolysaccharide-induced apoptosis and inflammatory cell infiltration in mouse lungs by inhibiting PI3K/Akt signaling

Yang Zhou et al.

Summary: This study found that Platycodon grandiflorum extract (PAE) attenuates lipopolysaccharide-induced lung injury and inflammation by inhibiting the PI3K/Akt signaling pathway. These findings provide a novel strategy for the potential application of PAE as a preventive agent for patients with acute lung injury (ALI).

CHINESE MEDICINE (2023)

Add to Collection
Article Chemistry, Multidisciplinary

An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis

Muhammad Arif et al.

Summary: This study identifies gene subnetworks associated with pulmonary fibrosis and proposes peripheral CB1R antagonism as a potential therapeutic target. The findings are based on integrated multi-omics data and validate the results in both mouse models and human patients.

ADVANCED SCIENCE (2023)

Add to Collection
Article Biochemistry & Molecular Biology

A novel pulmonary fibrosis murine model with immune-related liver injury

Kexin Jia et al.

Summary: This study successfully established a mouse model of AE-IPF that recapitulated the clinical features and pathological changes observed in AE-IPF patients, providing an appropriate experimental platform for investigating the underlying mechanisms of liver injury in AE-IPF.

ANIMAL MODELS AND EXPERIMENTAL MEDICINE (2023)

Add to Collection
Article Critical Care Medicine

Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Aoife N. McElroy et al.

Summary: The study on the association between TLR3 L412F polymorphism and acute exacerbation-related death in idiopathic pulmonary fibrosis (IPF) reveals that this polymorphism attenuates the immune responses of IPF lung cells to bacteria and dysregulates the lung microbiome in IPF patients.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection
Review Pathology

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

Benjamin J. Moss et al.

Summary: The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of various cell types and signaling pathways. Novel bioinformatics tools can help discover disease pathways, cell-specific mechanisms, and cell-cell interactions.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2022)

Add to Collection
Review Cell Biology

Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics

Shuchan Li et al.

Summary: Idiopathic pulmonary fibrosis is a progressive lung disease characterized by pulmonary function loss, while drug-induced interstitial lung disease is a severe adverse effect of certain drugs. Animal models play a key role in understanding the molecular mechanisms of PF pathogenesis and developing therapeutic strategies.

CELL BIOLOGY AND TOXICOLOGY (2022)

Add to Collection
Editorial Material Critical Care Medicine

An Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination A Case Report

Alexander Ghincea et al.

Summary: This case report explores a potential association between acute exacerbation of IPF (AE-IPF) and the BNT162b2 mRNA COVID-19 vaccination. The patient was successfully treated with a short course of glucocorticoids. Despite the need for further awareness of this adverse event, vaccination against preventable diseases is still highly recommended for vulnerable patients with chronic lung diseases such as IPF.

CHEST (2022)

Add to Collection
Article Medicine, General & Internal

Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19

Norihito Omote et al.

Summary: We report a case of acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) triggered by COVID-19. The patient tested positive for COVID-19 and imaging showed ground-glass opacity (GGO) consistent with usual interstitial pneumonia. High-dose steroids were effective in improving the pulmonary infiltrates and the patient was discharged without severe disability.

INTERNAL MEDICINE (2022)

Add to Collection
Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Complement protein C1q activates lung fibroblasts and exacerbates silica-induced pulmonary fibrosis in mice

Tatsuro Ogawa et al.

Summary: C1q, a complement protein, plays an important role in pulmonary fibrosis. This study found that inhibiting C1q could improve pulmonary fibrosis, while administration of C1q induced fibrotic changes. Further experiments revealed that C1q activated fibroblasts and type 2 alveolar epithelial cells, leading to the expression of fibrosis-related genes. These findings suggest that C1q may be a potential therapeutic target for pulmonary fibrosis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection
Article Biochemistry & Molecular Biology

ALKBH5 promotes lung fibroblast activation and silica-induced pulmonary fibrosis through miR-320a-3p and FOXM1

Wenqing Sun et al.

Summary: The study finds that ALKBH5 promotes silica-induced lung fibrosis through the miR-320a-3p/FOXM1 axis or direct targeting of FOXM1. Inhibition of ALKBH5 may be effective in treating lung fibrosis.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Trimetazidine, a metabolic modulator, attenuates silica-induced pulmonary fibrosis and decreases lactate levels and LDH activity in rats

Rehab S. Abdelrahman et al.

Summary: This study investigates the effects of the metabolic modulator trimetazidine (TMZ) on silica-induced pulmonary fibrosis using a rat model. The results demonstrate that TMZ attenuates silica-induced pulmonary fibrosis by suppressing excessive lactate production and regulating oxidative stress.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2022)

Add to Collection
Review Surgery

Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes

Akira Iyoda et al.

Summary: Postoperative exacerbation of interstitial pneumonia in patients with interstitial lung disease and lung cancer is a serious problem that requires identification of risk factors. Treatment of patients with idiopathic forms of interstitial lung disease, such as idiopathic pulmonary fibrosis, poses challenges, particularly when undergoing surgical treatments for lung cancer.

SURGERY TODAY (2022)

Add to Collection
Article Multidisciplinary Sciences

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

Corina N. D'Alessandro-Gabazza et al.

Summary: The authors demonstrate that a monoclonal neutralizing antibody against the proapoptotic peptide corisin, derived from the lung microbiota, can improve acute exacerbation of pulmonary fibrosis and the severity of endotoxin-induced acute lung injury in mice. The study provides insights into the processing and release of corisin and shows that an anticorisin monoclonal antibody can ameliorate lung fibrosis and acute lung injury. These findings highlight the role of corisin in the pathogenesis of the diseases and offer a novel approach to treating the incurable disease.

NATURE COMMUNICATIONS (2022)

Add to Collection
Review Respiratory System

Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation

Kakuhiro Yamaguchi et al.

Summary: RAGE receptor plays a homeostatic role in the lung, but its abnormal binding may lead to lung injury and the occurrence of ILD, including IPF. IPF patients have a poor prognosis, with AE-IPF being one of the main causes of death. ILD is frequently observed in patients with lung cancer, and procedures or chemotherapy may trigger AE-ILD, leading to increased mortality.

RESPIRATORY INVESTIGATION (2022)

Add to Collection
Article Medicine, Research & Experimental

Unilateral acute lung injury in pig: a promising animal model

Johannes Geilen et al.

Summary: This study developed a method of creating a unilateral acute lung injury model in pigs and evaluated the key parameters. The experiment confirmed the successful induction of unilateral lung injury in pigs using this model, reducing the number of animals required for experiments while obtaining valid conclusions. The results of the study suggest that this model has good clinical application value.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection
Article Critical Care Medicine

Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis

Toshio Suzuki et al.

Summary: This study found that TBXA2R is associated with oxidative stress and fibroblast activation in lung fibrosis, and TBXA2R antagonists may have potential in the treatment of pulmonary fibrosis.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Add to Collection
Review Medicine, General & Internal

Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis

Gabrielle Y. Liu et al.

Summary: Similar to IPF, other interstitial lung diseases can develop progressive pulmonary fibrosis and require the study of new treatment methods and biomarkers for personalized care.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection
Article Immunology

Elevated Expression of Growth Differentiation Factor-15 Is Associated With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Mengshu Cao et al.

Summary: The level of GDF-15 is significantly elevated in patients with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) and is related to disease severity and survival. Serum GDF-15 level may be a potential biomarker for AE occurrence and survival in IPF patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection
Article Biotechnology & Applied Microbiology

PM2.5 Exposure Induces Lung Injury and Fibrosis by Regulating Ferroptosis via TGF-β Signaling

Li Guo et al.

Summary: In this study, the effect of PM2.5 on ferroptosis in lung fibrosis and the related molecular mechanisms were explored. It was found that PM2.5 exposure induced lung injury and fibrosis by promoting ferroptosis through the TGF-beta signaling pathway.

DISEASE MARKERS (2022)

Add to Collection
Article Cell Biology

A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice

Celine-Hivda Yegen et al.

Summary: Researchers have developed an experimental mice model of lung fibrosis AE, mimicking IPF-AE at various levels, which could be useful for preclinical trials.

CELLS (2022)

Add to Collection
Article Medicine, Research & Experimental

Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis

Agata Radwanska et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by scar tissue formation in the lungs. In this study, the researchers found that IPF patient-derived pulmonary ECM can induce fibrotic response in normal human lung fibroblasts. They identified GDF15 as one of the significantly upregulated proteins in the diseased ECM, and demonstrated its role in fibroblast activation and differentiation in promoting lung fibrosis.

JCI INSIGHT (2022)

Add to Collection
Review Cell Biology

Application of the transgenic pig model in biomedical research: A review

Jialin Wei et al.

Summary: The large animal model is crucial in preclinical research. Transgenic pigs, due to advancements in genetic engineering, have shown superiority in disease research, particularly in metabolic diseases, neurodegenerative diseases, and genetic diseases.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Add to Collection
Article Medicine, Research & Experimental

Essential role of IL-17 in acute exacerbation of pulmonary fibrosis induced by non-typeable Haemophilus influenzae

Shengsen Chen et al.

Summary: This study established a mouse model of bacterium-induced acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) and found that the IL-17 gene is essential for the development of AE-IPF.

THERANOSTICS (2022)

Add to Collection
Article Medicine, Research & Experimental

The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis

Jiurong Liang et al.

Summary: This study identified a deficiency of the zinc transporter SLC39A8 (ZIP8) in Type 2 alveolar epithelial cells (AEC2s) from both idiopathic pulmonary fibrosis (IPF) lungs and lungs of old mice, which is associated with impaired AEC2 renewal capacity and enhanced lung fibrosis. The regulation of AEC2 progenitor function by ZIP8 is dependent on SIRT1. Replenishment with exogenous zinc and activation of SIRT1 promote self-renewal and differentiation of AEC2s, and therapeutic strategies targeting zinc metabolism and SIRT1 signaling could potentially improve AEC2 progenitor function and mitigate fibrogenesis.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection
Article Nutrition & Dietetics

Acute exacerbation of idiopathic pulmonary fibrosis model by small amount of lipopolysaccharide in rats

Hikaru Miyamoto et al.

Summary: The article presents a rat model for assessing acute exacerbation in cases of idiopathic pulmonary fibrosis, which can mimic the pathophysiological changes in humans.

JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2022)

Add to Collection
Article Critical Care Medicine

Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis

Changfu Yao et al.

Summary: The study demonstrates that senescence of AT2 cells is sufficient to drive progressive pulmonary fibrosis, and interventions targeting p53 activation or senescence can block fibrogenesis. Early attenuation of senescence-related pathways and elimination of senescent cells are promising therapeutic approaches to prevent pulmonary fibrosis.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Lung Myofibroblasts Promote Macrophage Profibrotic Activity through Lactate-induced Histone Lactylation

Huachun Cui et al.

Summary: This study demonstrates that in lung fibrosis, myofibroblasts enhance glycolysis to produce lactate, which regulates the pathogenic phenotype of alveolar macrophages. Lactate induces profibrotic gene expression in macrophages, promoting the fibrotic process.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Role of bone marrow-derived mesenchymal stem cells in alleviating pulmonary epithelium damage and extracellular matrix remodeling in a rat model of lung fibrosis induced by amiodarone

Alyaa S. Abdel Halim et al.

Summary: The study found that treatment with bone marrow-derived mesenchymal stem cells (BM-MSCs) or their conditioned media (CM) has potential therapeutic effects on amiodarone-induced pulmonary fibrosis, reducing lung injury, decreasing collagen accumulation, and showing improved treatment efficacy with longer treatment duration.

BIOTECHNIC & HISTOCHEMISTRY (2021)

Add to Collection
Article Chemistry, Medicinal

Arenaria kansuensis attenuates pulmonary fibrosis in mice via the activation of Nrf2 pathway and the inhibition ofNF-kB/TGF-beta1/Smad2/3 pathway

Yulei Cui et al.

Summary: A. kansuensis ethanol extract (AE) has a significant protective effect against pulmonary fibrosis, potentially due to its activation of the Nrf2 pathway and inhibition of the NF-kB/TGF-beta1/Smad2/3 pathway, leading to reduced collagen deposition, improved lung tissue structure, and decreased inflammatory infiltrations.

PHYTOTHERAPY RESEARCH (2021)

Add to Collection
Article Physiology

Role of the COX2-PGE2 axis in S. pneumoniae-induced exacerbation of experimental fibrosis

Tina Bormann et al.

Summary: PGE2 levels are significantly increased in lung tissue of patients with interstitial lung disease, and play important roles in infection-induced exacerbation of lung fibrosis. Interventions targeting the COX2-PGE2 axis can ameliorate lung fibrosis, with PGE2 having dual roles in fibrosis exacerbation.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice

Elizabeth F. Redente et al.

Summary: A simplified repetitive bleomycin instillation strategy was developed to mimic persistent and progressive pulmonary fibrosis, recapitulating histological and radiographic characteristics of idiopathic pulmonary fibrosis (IPF). Compared to the single bleomycin instillation model, this simplified repetitive model may be better suited for addressing mechanistic questions about IPF pathogenesis and preclinical studies of antifibrotic drug candidates.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Evaluation of microRNA expression in a sheep model for lung fibrosis

Udari Eshani Perera et al.

Summary: The study identified 49 differentially expressed miRNAs in a sheep model for lung fibrosis, with miRNA families such as miR-29, miR-26, miR-30, let-7, miR-21, miR-19, miR-17, and miR-199 showing aberrant expression in both sheep and mouse models, similar to what is observed in IPF cases. Pathway enrichment analyses suggest that the sheep model could potentially uncover previously unrecognized biological pathways associated with lung fibrosis.

BMC GENOMICS (2021)

Add to Collection
Editorial Material Critical Care Medicine

Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis: Combining Real World and Clinical Trials for Totality of Evidence

Yet H. Khor

CHEST (2021)

Add to Collection
Review Pharmacology & Pharmacy

Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications

Toyoshi Yanagihara et al.

Summary: IPF is a chronic progressive lung disease with high mortality. Despite recent therapeutic advancements, there is a major interest in identifying new therapeutic targets and precision approaches to therapy. Novel technologies such as transcriptomics and serum biomarkers will play a key role in guiding future drug development and therapeutic decision making.

EXPERT OPINION ON THERAPEUTIC TARGETS (2021)

Add to Collection
Article Medicine, Research & Experimental

Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway

Jiucui Li et al.

Summary: Panaxydol (PX) isolated from Panax ginseng roots attenuates ferroptosis against LPS-induced ALI via the Keap1-Nrf2/HO-1 pathway, showing promising therapeutic potential for ALI treatment.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Add to Collection
Review Cell Biology

Importance of the pig as a human biomedical model

Joan K. Lunney et al.

Summary: Pigs have significant potential as biomedical models for studying human developmental processes, congenital diseases, and pathogen response mechanisms, as well as serving as xenotransplant organ donors and tools for vaccine and drug design. The similarities between pigs and humans in anatomy, physiology, immunology, and genetics enhance their potential as human models. Therefore, utilizing animal models that closely resemble humans, such as pigs, is crucial for relevant and reproducible research.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Influence of miRNA-30a-5p on Pulmonary Fibrosis in Mice with Streptococcus pneumoniae Infection through Regulation of Autophagy by Beclin-1

Hanyu Liu et al.

Summary: The study demonstrated that silencing miRNA-30a-5p expression can promote the expression of Beclin-1 to accelerate autophagy, thereby treating pulmonary fibrosis in mice with Streptococcus pneumoniae infection.

BIOMED RESEARCH INTERNATIONAL (2021)

Add to Collection
Article Respiratory System

Increased Levels of ER Stress and Apoptosis in a Sheep Model for Pulmonary Fibrosis Are Alleviated by In Vivo Blockade of the KCa3.1 Ion Channel

Udari E. Perera et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive damage to lung tissues, potentially linked with apoptosis and ER stress. Targeting the calcium-activated potassium ion channel KCa3.1 may offer potential therapeutic benefits for IPF, as it has been shown to reduce ER stress and apoptosis in type II AECs and lung macrophages, contributing to its anti-fibrotic effects.

CANADIAN RESPIRATORY JOURNAL (2021)

Add to Collection
Article Immunology

UUO induces lung fibrosis with macrophage-myofibroblast transition in rats

Fan Yang et al.

Summary: Chronic kidney disease progressing to uremia is often associated with lung damage, with inflammatory macrophages possibly playing a role in lung fibrosis. MMT cells appear to be crucial in lung fibrosis and have a predominant M2 phenotype, which can be attenuated by treatment with eplerenone, suggesting a potential therapeutic approach for kidney damage and lung protection in UUO-induced injury.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection
Article Environmental Sciences

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis

Ioannis Tomos et al.

Summary: The study found that long-term personal exposure to increased concentrations of air pollutants is an independent risk factor for AE-IPF. Inflammatory mediators involved in lung repair mechanisms play a role in this association.

ENVIRONMENTAL HEALTH (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases

Julie Tanguy et al.

Summary: Interstitial lung diseases (ILDs) encompass a wide range of diseases, each with unique clinical patterns and features, making predicting disease progression challenging for individual patients. Heat shock proteins (HSPs) are implicated in fibrogenesis and may hold promise as therapeutic targets and biomarkers in ILDs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Review Immunology

Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis

Amit Kishore et al.

Summary: This review highlights the significant impact of macrophage polarization on the development and progression of lung fibrosis by regulating the production and function of inflammatory and fibrogenic mediators. It also emphasizes the role of miRNAs in regulating lung injury and fibrotic responses, with extracellular exosomal-miRNAs potentially promoting disease progression, particularly those derived from M2 macrophages.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Editorial Material Physiology

The emergence of preclinical studies on the role of the microbiome in lung development and experimental animal models of bronchopulmonary dysplasia

Francisco Casado et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)

Add to Collection
Article Respiratory System

GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation

Soo Jung Cho et al.

THORAX (2020)

Add to Collection
Article Veterinary Sciences

Update on Canine Idiopathic Pulmonary Fibrosis in West Highland White Terriers

Henna P. Laurila et al.

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2020)

Add to Collection
Review Pharmacology & Pharmacy

Current models of pulmonary fibrosis for future drug discovery efforts

Toyoshi Yanagihara et al.

EXPERT OPINION ON DRUG DISCOVERY (2020)

Add to Collection
Article Toxicology

Development of chronic lung injury and pulmonary fibrosis in mice following acute exposure to nitrogen mustard

Pavel Solopov et al.

INHALATION TOXICOLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis

Corina N. D'Alessandro-Gabazza et al.

NATURE COMMUNICATIONS (2020)

Add to Collection
Review Medicine, General & Internal

Spectrum of Fibrotic Lung Diseases

Marlies Wijsenbeek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Review Respiratory System

Silicosis: An Update and Guide for Clinicians

Silpa Krefft et al.

CLINICS IN CHEST MEDICINE (2020)

Add to Collection
Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Add to Collection
Article Multidisciplinary Sciences

Technical advance: The use of tree shrews as a model of pulmonary fibrosis

Jennifer L. Larson-Casey et al.

PLOS ONE (2020)

Add to Collection
Review Respiratory System

The importance of interventional timing in the bleomycin model of pulmonary fibrosis

Philipp Kolb et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Add to Collection
Article Biochemistry & Molecular Biology

IL-9 Blockade Suppresses Silica-induced Lung Inflammation and Fibrosis in Mice

Naoya Sugimoto et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Add to Collection
Article Immunology

Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice

Alessandro Venosa et al.

JOURNAL OF IMMUNOLOGY (2019)

Add to Collection
Article Respiratory System

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis

Rachele Invernizzi et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Add to Collection
Review Respiratory System

What have we learned from basic science studies on idiopathic pulmonary fibrosis?

Toyoshi Yanagihara et al.

EUROPEAN RESPIRATORY REVIEW (2019)

Add to Collection
Article Immunology

A homozygous SFTPA1 mutation drives necroptosis of type II alveolar epithelial cells in patients with idiopathic pulmonary fibrosis

Akio Takezaki et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Add to Collection
Review Radiology, Nuclear Medicine & Medical Imaging

Preclinical models of radiation-induced lung damage: challenges and opportunities for small animal radiotherapy

Mihaela Ghita et al.

BRITISH JOURNAL OF RADIOLOGY (2019)

Add to Collection
Article Cell Biology

IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis

Tao Chen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Add to Collection
Article Cell Biology

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Dong Weng et al.

MEDIATORS OF INFLAMMATION (2019)

Add to Collection
Article Immunology

Acute Hypoxemic Respiratory Failure and Native Lung Idiopathic Pulmonary Fibrosis Exacerbation in Single-lung Transplant Patients with Cytomegalovirus Disease: A Case Series

Robert M. Marron et al.

TRANSPLANTATION PROCEEDINGS (2019)

Add to Collection
Article Respiratory System

The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis

Tetsuya Hanaka et al.

BMC PULMONARY MEDICINE (2019)

Add to Collection
Article Medicine, Research & Experimental

An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis

Jeremy Katzen et al.

JCI INSIGHT (2019)

Add to Collection
Article Environmental Sciences

Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway

Lawei Yang et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2018)

Add to Collection
Review Pharmacology & Pharmacy

Engineered cell and tissue models of pulmonary fibrosis

Aswin Sundarakrishnan et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Add to Collection
Article Respiratory System

Optimising experimental research in respiratory diseases: an ERS statement

Philippe Bonniaud et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

Add to Collection
Article Environmental Sciences

Low-dose cadmium exposure exacerbates polyhexamethylene guanidine-induced lung fibrosis in mice

Min-Seok Kim et al.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2018)

Add to Collection
Review Pharmacology & Pharmacy

Use of animal models in IPF research

R. Carrington et al.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases

Takeshi Saraya et al.

RESPIRATORY MEDICINE (2018)

Add to Collection
Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Add to Collection
Article Medicine, Research & Experimental

Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis

Shin-Ichi Nureki et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection
Review Respiratory System

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis

Meihua Qiu et al.

CLINICAL RESPIRATORY JOURNAL (2018)

Add to Collection
Article Medicine, General & Internal

Clinical Characteristics Based on the New Criteria of Acute Exacerbation in Patients with Idiopathic Pulmonary Fibrosis

Tomoo Kishaba et al.

EURASIAN JOURNAL OF MEDICINE (2018)

Add to Collection
Review Respiratory System

Acute exacerbations of progressive-fibrosing interstitial lung diseases

Martin Kolb et al.

EUROPEAN RESPIRATORY REVIEW (2018)

Add to Collection
Article Respiratory System

Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo

Mareike Lehmann et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection
Article Respiratory System

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis

Harold R. Collard et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection
Review Medicine, General & Internal

Idiopathic pulmonary fibrosis

Luca Richeldi et al.

LANCET (2017)

Add to Collection
Article Respiratory System

Development of a non-infectious rat model of acute exacerbation of idiopathic pulmonary fibrosis

Shan-Shan Chen et al.

JOURNAL OF THORACIC DISEASE (2017)

Add to Collection
Article Immunology

Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Hui Qiu et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection
Article Biochemistry & Molecular Biology

An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis

R. Gisli Jenkins et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)

Add to Collection
Article Respiratory System

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis

Philip L. Molyneaux et al.

RESPIRATORY RESEARCH (2017)

Add to Collection
Review Respiratory System

Invasive diagnostic techniques in idiopathic interstitial pneumonias

Venerino Poletti et al.

RESPIROLOGY (2016)

Add to Collection
Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Add to Collection
Article Respiratory System

Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis

Ya-Ru Wei et al.

EXPERIMENTAL LUNG RESEARCH (2016)

Add to Collection
Article Cell Biology

Plasma Leptin Is Elevated in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Mengshu Cao et al.

MEDIATORS OF INFLAMMATION (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases

Toru Kimura et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2015)

Add to Collection
Article Multidisciplinary Sciences

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Jonas Christian Schupp et al.

PLOS ONE (2015)

Add to Collection
Article Respiratory System

Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin

Sarah Knippenberg et al.

THORAX (2015)

Add to Collection
Article Respiratory System

Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis

Louise Organ et al.

BMC PULMONARY MEDICINE (2015)

Add to Collection
Article Respiratory System

Viruses in Idiopathic Pulmonary Fibrosis Etiology and Exacerbation

Bethany B. Moore et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2015)

Add to Collection
Article Respiratory System

Risk factors for acute exacerbation of idiopathic pulmonary fibrosis - Extended analysis of pirfenidone trial in Japan

Yasuhiro Kondoh et al.

RESPIRATORY INVESTIGATION (2015)

Add to Collection
Article Physiology

γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis

Shanna L. Ashley et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)

Add to Collection
Article Critical Care Medicine

Chronic Pleuropulmonary Fibrosis and Elastosis of Aged Donkeys Similarities to Human Pleuroparenchymal Fibroelastosis

Amy Miele et al.

CHEST (2014)

Add to Collection
Article Respiratory System

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure

Kerri A. Johannson et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

Add to Collection
Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection
Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection
Article Multidisciplinary Sciences

Intratracheal Instillation of High Dose Adenoviral Vectors Is Sufficient to Induce Lung Injury and Fibrosis in Mice

Qiyuan Zhou et al.

PLOS ONE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis

Shinichiro Ohshimo et al.

RESPIRATORY MEDICINE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials

C. P. Atkins et al.

RESPIRATORY MEDICINE (2014)

Add to Collection
Article Critical Care Medicine

Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study

MeiLan K. Han et al.

LANCET RESPIRATORY MEDICINE (2014)

Add to Collection
Article Critical Care Medicine

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection
Article Critical Care Medicine

Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses

Rehan A. Kahloon et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Add to Collection
Review Biochemistry & Molecular Biology

Animal Models of Fibrotic Lung Disease

Bethany B. Moore et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)

Add to Collection
Article Biochemistry & Molecular Biology

Role of Endoplasmic Reticulum Stress in Age-Related Susceptibility to Lung Fibrosis

Edilson Torres-Gonzalez et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)

Add to Collection
Article Geriatrics & Gerontology

Pulmonary Fibrosis Induced by γ-Herpesvirus in Aged Mice Is Associated With Increased Fibroblast Responsiveness to Transforming Growth Factor-β

Payal N. Naik et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2012)

Add to Collection
Review Respiratory System

An earlier and more confident diagnosis of idiopathic pulmonary fibrosis

Roland M. du Bois

EUROPEAN RESPIRATORY REVIEW (2012)

Add to Collection
Article Physiology

Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types

Joshua S. Stoolman et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)

Add to Collection
Article Critical Care Medicine

Leptin Promotes Fibroproliferative Acute Respiratory Distress Syndrome by Inhibiting Peroxisome Proliferator-activated Receptor-γ

Manu Jain et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Add to Collection
Article Critical Care Medicine

Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Sharon Chao Wootton et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Add to Collection
Article Medicine, General & Internal

Progress Toward Improving Animal Models for Idiopathic Pulmonary Fibrosis

Amber L. Degryse et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)

Add to Collection
Article Respiratory System

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome

J. W. Song et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Add to Collection
Article Critical Care Medicine

Targeted Injury of Type II Alveolar Epithelial Cells Induces Pulmonary Fibrosis

Thomas H. Sisson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Add to Collection
Article Medicine, General & Internal

Acute Exacerbation of Idiopathic Pulmonary Fibrosis after Pandemic Influenza A (H1N1) Vaccination

Yukihiro Umeda et al.

INTERNAL MEDICINE (2010)

Add to Collection
Article Respiratory System

Risk of Acute Exacerbation After Video-assisted Thoracoscopic Lung Biopsy for Interstitial Lung Disease

Masashi Bando et al.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY (2009)

Add to Collection
Review Physiology

Murine models of pulmonary fibrosis

Bethany B. Moore et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)

Add to Collection
Article Critical Care Medicine

Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus

Tracy R. McMillan et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Add to Collection
Article Critical Care Medicine

Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis

Brent W. Kinder et al.

CHEST (2008)

Add to Collection
Article Critical Care Medicine

Acute exacerbations of idiopathic pulmonary fibrosis

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Add to Collection
Article Pathology

Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to Immunodeficient mice

Elizabeth M. Pierce et al.

AMERICAN JOURNAL OF PATHOLOGY (2007)

Add to Collection
Article Immunology

Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis

CG Lee et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2004)

Add to Collection
Review Cell Biology

Myofibroblasts and mechano-regulation of connective tissue remodelling

JJ Tomasek et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)

Add to Collection
Article Immunology

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1

CG Lee et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2001)

Add to Collection
Review Critical Care Medicine

Bleomycin-induced pneumonitis

S Sleijfer

CHEST (2001)

Add to Collection
Article Medicine, Research & Experimental

Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis

M Kolb et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.